- Exchange: NYSE MKT LLC
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
PROLOR Biotech Inc
+ Add to WatchlistPBTH:US
6.3300 USD 0.0800 1.25%As of 20:04:03 ET on 05/24/2013.
Snapshot for PROLOR Biotech Inc (PBTH)
| Open: | 6.3600 | Day's Range: | 6.3300 - 6.4100 | Volume: | 137,703 |
|---|---|---|---|---|---|
| Previous Close: | 6.3300 | 52wk Range: | 4.2500 - 6.5600 | 1-Yr Rtn: | +22.91% |
Key Statistics for PBTH
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.2800 |
| Est. EPS (USD) (12/2013) | -0.3500 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 403.10 |
| Shares Outstanding (M) | 63.68 |
| 30 Day Average Volume | 435,459 |
| Price/Book (mrq) | 13.4758 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PBTH
Company Profile & Key Executives for PBTH
PROLOR Biotech Inc. is a biopharmaceutical company. The Company develops therapeutic proteins. PROLOR offers treatment by using naturally occurring amino acid sequence to slow the removal of therapeutic proteins from the body without increasing toxicity or altering the overall biological activity.
| Abraham Havron "Avri"Chief Executive Officer | Shai NovikPresident |
| Steve SchaefferChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PBTH News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page